Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VIII immunogenicity

M G Jacquemin, J M Saint-Remy

    Haemophilia : the Official Journal of the World Federation of Hemophilia
    |January 5, 1999
    PubMed
    Summary
    This summary is machine-generated.

    Understanding factor VIII immunogenicity in hemophilia A is key. This review explores how self-tolerance is established, maintained, and broken, considering disease severity and patient factors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pathogenesis and Management of Acquired Haemophilia.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.

    Haemophilia : the official journal of the World Federation of Hemophilia·2007
    Same author

    The use of antibodies to coagulation factors for anticoagulant therapy.

    Current medicinal chemistry·2004
    Same author

    Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII.

    Blood·2001
    Same author

    Hemophilia factor VIII therapy. B- and T-cell tolerance: from basic concepts to clinical practice.

    Haematologica·2001
    Same author

    Antigenicity of putative phospholipid membrane-binding residues in factor VIII.

    Blood·2001
    Same journal

    Use of an Oral Health-Related Quality of Life Instrument to Measure Unmet Dental Care Needs in Adults With Inherited Bleeding Disorders.

    Haemophilia : the official journal of the World Federation of Hemophilia·2026
    Same journal

    Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross-Sectional Study of Patient- and Joint-Level Analyses Using Musculoskeletal Ultrasound.

    Haemophilia : the official journal of the World Federation of Hemophilia·2026
    Same journal

    Utilisation and Perceived Value of Genetic Counsellors Within US Haemophilia Treatment Centres.

    Haemophilia : the official journal of the World Federation of Hemophilia·2026
    Same journal

    Monitoring of Coagulation Potential of Efanesoctocog Alfa in Haemophilia A: Insights From Conventional and Global Hemostasis Assays.

    Haemophilia : the official journal of the World Federation of Hemophilia·2026
    Same journal

    Perceived Barriers to Healthcare Access Among Paediatric Patients With Haemophilia in Cambodia: A Cross-Sectional Survey.

    Haemophilia : the official journal of the World Federation of Hemophilia·2026
    Same journal

    Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

    Haemophilia : the official journal of the World Federation of Hemophilia·2026
    See all related articles

    Area of Science:

    • Immunology
    • Hematology
    • Genetics

    Background:

    • Factor VIII immunogenicity is a significant challenge in hemophilia A treatment.
    • Host factors and the characteristics of factor VIII preparations influence immune responses.
    • Understanding self-tolerance mechanisms is crucial for managing immune complications.

    Purpose of the Study:

    • To review the fundamental mechanisms of self-tolerance in hemophilia A.
    • To emphasize the role of disease severity in immune tolerance.
    • To discuss immune responses in healthy individuals and those with factor VIII autoantibodies.

    Main Methods:

    • Literature review of immunological and hematological studies.
    • Analysis of factors influencing factor VIII immunogenicity.

    Related Experiment Videos

  • Comparative discussion of tolerance in different patient populations.

    • Main Results:

    • Immunogenicity is multifactorial, involving host susceptibility and therapeutic product characteristics.
    • Disease severity significantly impacts the establishment and maintenance of self-tolerance.
    • Breakdown of tolerance can occur, leading to autoantibody formation.

    Conclusions:

    • Tolerance to factor VIII is a complex process influenced by disease severity and external factors.
    • Further research into tolerance mechanisms can inform strategies to mitigate immunogenicity in hemophilia A.
    • Insights gained are relevant to both hemophilia A patients and healthy individuals.